Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: TAUNS Laboratories,Inc.

Market Cap 51.89B 322M 281M 260M 243M 456M 30.36B 459M 3.08B 1.19B 14.94B 1.21B 1.18B P/E 2025
8.67x
P/E 2026 * 9.79x
Enterprise Value 58.72B 364M 317M 294M 275M 516M 34.36B 519M 3.49B 1.35B 16.91B 1.37B 1.34B EV / Sales 2025
3.23x
EV / Sales 2026 * 4.06x
Free-Float
29.79%
Yield 2025
5.2%
Yield 2026 * 7.24%
1 day-0.81%
1 week+0.41%
Current month-1.81%
1 month-3.37%
3 months-7.41%
6 months-7.59%
Current year-4.32%
1 week 484
Extreme 484
492
1 month 484
Extreme 484
503
Current year 484
Extreme 484
568
1 year 484
Extreme 484
603
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 01/05/2014
Director of Finance/CFO 66 01/11/2018
Corporate Officer/Principal 38 01/07/2022
Director TitleAgeSince
Director/Board Member 62 01/09/2020
Director/Board Member 52 01/04/2016
Director/Board Member 38 01/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%+0.41%-17.04% - 322M
+2.07%+0.12%+168.17%+253.96% 17.47B
+2.15%+1.85%-42.64%-22.56% 9.33B
+0.65%-0.63%+31.15%+11.83% 6.76B
+3.42%+2.78%-32.22% - 5.22B
-1.64%-3.63%-27.65%-32.78% 4.88B
+10.00%+20.71%+105.80%+104.59% 4.54B
+8.17%+20.51%+221.51%-39.98% 4.41B
+2.07%-2.17%-31.05%-33.48% 3.95B
-1.74%-2.46%-17.42%-43.06% 2.57B
Average +2.43%+3.72%+35.86%+24.82% 5.95B
Weighted average by Cap. +2.61%+3.16%+62.77%+77.93%

Financials

2025 2026 *
Net sales 19.06B 118M 103M 95.44M 89.35M 168M 11.15B 169M 1.13B 439M 5.49B 444M 434M 14.76B 91.5M 79.78M 73.89M 69.17M 130M 8.63B 131M 877M 340M 4.25B 343M 336M
Net income 6.5B 40.3M 35.14M 32.55M 30.47M 57.14M 3.8B 57.48M 386M 150M 1.87B 151M 148M 5.2B 32.25M 28.12M 26.04M 24.38M 45.73M 3.04B 46M 309M 120M 1.5B 121M 118M
Net Debt 6.83B 42.35M 36.92M 34.2M 32.01M 60.04M 4B 60.4M 406M 157M 1.97B 159M 156M 7.99B 49.57M 43.22M 40.03M 37.47M 70.28M 4.68B 70.7M 475M 184M 2.3B 186M 182M
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
19/06/26 487.00 ¥ -0.81% 215,600
18/06/26 491.00 ¥ +0.61% 357,000
17/06/26 488.00 ¥ +0.21% 156,600
16/06/26 487.00 ¥ +0.62% 237,400
15/06/26 484.00 ¥ -0.21% 297,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
487.00JPY
Average target price
420.00JPY
Spread / Average Target
-13.76%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 197A Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!